Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee:

First Page		Document Content
Date: 2007-07-09 08:23:19 HRPC Satraplatin GPC Biotech		Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee: Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 24,39 KB Share Document on Facebook

	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waivers under 18 U.S.C. §208(b)(3) and 21 U.S.C. $355 (n)(4) Otis Brawley, M.D. Commi.ttee: DocID: ylN8 - View Document
	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 21 U.S.C. 355(n)(4) Michael Perry, M.D. Committee: Oncologic Drugs Advisory Committee DocID: xLAu - View Document
	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and a Waiver under 21 U.S.C. $355 (n)(4) Pamela Haylock, R.N., M.A. Committee: DocID: xKmb - View Document
	Acknowledgement and Consent for Disclosure of Potential Conflict(s) of Interest and Waiver under 18 U.S .C. §208(b)(3) John T. Farrar, M.D. Committee: DocID: xIzD - View Document
	PDF Document DocID: me2w - View Document